Abstract
We explore the interaction of open innovation and intellectual property (IP) in two Chinese latecomer pharmaceutical firms in their catch-up process. Studying archival data, documentation, and interviews, we found that the two firms exhibited five periods that were characterised by different open innovation activities and R&D capabilities. In their early stages, the two firms lacked R&D functions; thus, they imported technologies and pursued production-oriented strategies. As they gradually entered into collaborations and established their R&D departments, open innovation and IP protection played important and dynamic roles in this process. Thus, a catch-up process involves not only acquiring technological capabilities and innovative competencies but also transforming a firm's capacity to strategies.
| Original language | English |
|---|---|
| Pages (from-to) | 1159-1175 |
| Number of pages | 17 |
| Journal | Technology Analysis & Strategic Management |
| Volume | 27 |
| Issue number | 10 |
| Early online date | 29 Jun 2015 |
| DOIs | |
| Publication status | Published - 26 Nov 2015 |
Keywords
- catch-up
- open innovation
- intellectual property
- developing economy
- pharmaceutical industry